Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis

Control of cutaneous leishmaniasis (CL) in the Americas is dependent on chemotherapy with parenteral pentavalent antimonials. High rates of treatment failure urge the search for predictive and prognostic markers of therapeutic responsiveness. In this study, we aimed to identify biomarkers of therape...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Pharmacol
Asıl Yazarlar: Vargas, Deninson Alejandro, Prieto, Miguel Dario, Martínez-Valencia, Alvaro José, Cossio, Alexandra, Burgess, Karl E. V., Burchmore, Richard J.S., Gómez, María Adelaida
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2019
Konular:
Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6595045/
https://ncbi.nlm.nih.gov/pubmed/31281253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00657
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller